For: | McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14(17): 2650-2661 [PMID: 18461650 DOI: 10.3748/wjg.14.2650] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i17/2650.htm |
Number | Citing Articles |
1 |
Azadeh Tavakoli, Judith Louise Flanagan. The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics?. Antibiotics 2019; 8(3): 88 doi: 10.3390/antibiotics8030088
|
2 |
Eamonn M.M. Quigley. Probiotics in the Management of Functional Bowel Disorders. Gastroenterology Clinics of North America 2012; 41(4): 805 doi: 10.1016/j.gtc.2012.08.005
|
3 |
Lynne Vernice McFarland, Tarkan Karatas, Ali Karatas. Strain-Specific and Outcome-Specific Efficacy of Probiotics for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3894914
|
4 |
Hafiza Maryam Yasmin, Tahir Zahoor, Ambreen Sagheer, Muhammad Nadeem, Adnan Khaliq, Rabia Iqbal, Samreen Ahsan, Zulfiqar Ahmad. Assessment of antagonistic activity of free and encapsulated Bifidobacterium bifidum against Salmonella. Journal of Food Safety 2018; 38(6) doi: 10.1111/jfs.12546
|
5 |
Viola Andresen, Jutta Keller, Christian Pehl, Michael Schemann, Jan Preiss, Peter Layer. Irritable Bowel Syndrome. Deutsches Ärzteblatt international 2011; doi: 10.3238/arztebl.2011.0751
|
6 |
Donald N. Tsynman, Savanna Thor, Joyann A. Kroser. Treatment of Irritable Bowel Syndrome in Women. Gastroenterology Clinics of North America 2011; 40(2): 265 doi: 10.1016/j.gtc.2011.03.012
|
7 |
Fergus Shanahan, Eamonn M.M. Quigley. Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies. Gastroenterology 2014; 146(6): 1554 doi: 10.1053/j.gastro.2014.01.050
|
8 |
G. C. Parkes, J. D. Sanderson, K. Whelan. Treating irritable bowel syndrome with probiotics: the evidence. Proceedings of the Nutrition Society 2010; 69(2): 187 doi: 10.1017/S002966511000011X
|
9 |
Richard A. Schatz, Baharak Moshiree. Gastrointestinal and Hepatic Disease in Fibromyalgia. Rheumatic Disease Clinics of North America 2018; 44(1): 131 doi: 10.1016/j.rdc.2017.09.009
|
10 |
Marwa M. El-Dalatony, Mostafa El-Sheekh, Xiangkai Li. Gut Remediation of Environmental Pollutants. 2020; : 169 doi: 10.1007/978-981-15-4759-1_6
|
11 |
Carmelo Scarpignato, Anna Bertelé, Antonio Tursi. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1): S70 doi: 10.1097/MCG.0000000000000641
|
12 |
Mohammad Mehdi Ommati, Huifeng Li, Akram Jamshidzadeh, Fereshteh Khoshghadam, Socorro Retana-Márquez, Yu Lu, Omid Farshad, Mohammad Hasan Nategh Ahmadi, Ahmad Gholami, Reza Heidari. The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(2): 247 doi: 10.1007/s00210-021-02177-0
|
13 |
L. V. McFarland. From Yaks to Yogurt: The History, Development, and Current Use of Probiotics. Clinical Infectious Diseases 2015; 60(suppl 2): S85 doi: 10.1093/cid/civ054
|
14 |
Félix Millán Rodríguez, Laia Sabiote Rubio, Irene Girón Nanne, Francisco Sánchez Martín, Esteban Emiliani, Oriol Angerri Feu. The relationship between calcium oxalate lithiasis and chronic proinflammatory intestinal dysbiosis pattern: a prospective study. Urolithiasis 2020; 48(4): 321 doi: 10.1007/s00240-020-01181-y
|
15 |
Mitchell L Jones, Christopher J Martoni, Jorge G Ganopolsky, Imran Sulemankhil, Peter Ghali, Satya Prakash. Improvement of gastrointestinal health status in subjects consumingLactobacillus reuteriNCIMB 30242 capsules: apost-hocanalysis of a randomized controlled trial. Expert Opinion on Biological Therapy 2013; 13(12): 1643 doi: 10.1517/14712598.2013.833601
|
16 |
Ulrike Voß, Anne Lewerenz, Karen Nieber. Sex and Gender Differences in Pharmacology. Handbook of Experimental Pharmacology 2013; 214: 473 doi: 10.1007/978-3-642-30726-3_21
|
17 |
Eamonn M. M. Quigley, Fergus Shanahan. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. Advances in Experimental Medicine and Biology 2014; 817: 417 doi: 10.1007/978-1-4939-0897-4_19
|
18 |
Bian Tiequn, Chao Guanqun, Zhang Shuo. Therapeutic Effects of Lactobacillus in Treating Irritable Bowel Syndrome: A Meta-analysis. Internal Medicine 2015; 54(3): 243 doi: 10.2169/internalmedicine.54.2710
|
19 |
Marika Mikelsaar, Veronica Lazar, Andrew Onderdonk, Gilanfranco Donelli. Do probiotic preparations for humans really have efficacy?. Microbial Ecology in Health and Disease 2011; 22(1): 10128 doi: 10.3402/mehd.v22i0.10128
|
20 |
Ritu Dahiya, Harpal S. Buttar, Suresh K. Gupta. Handbook of Nutraceuticals and Natural Products. 2022; : 397 doi: 10.1002/9781119746843.ch30
|
21 |
Duane Charbonneau, Roger D. Gibb, Eamonn M.M. Quigley. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes 2013; 4(3): 201 doi: 10.4161/gmic.24196
|
22 |
Elisa Bertazzoni, Gianfranco Donelli, Tore Midtvedt, Jacques Nicoli, Yolanda Sanz. Probiotics and clinical effects: is the number what counts?. Journal of Chemotherapy 2013; 25(4): 193 doi: 10.1179/1973947813Y.0000000078
|
23 |
Luis Fontana, Miriam Bermudez-Brito, Julio Plaza-Diaz, Sergio Muñoz-Quezada, Angel Gil. Sources, isolation, characterisation and evaluation of probiotics. British Journal of Nutrition 2013; 109(S2): S35 doi: 10.1017/S0007114512004011
|
24 |
Cheryl Stevenson, Renée Blaauw, Ernst Fredericks, Janicke Visser, Saartjie Roux. Probiotic effect and dietary correlations on faecal microbiota profiles in irritable bowel syndrome. South African Journal of Clinical Nutrition 2021; 34(3): 84 doi: 10.1080/16070658.2019.1697038
|
25 |
Perry Hookman, Jamie S Barkin. <italic>Clostridium difficile</italic> associated infection, diarrhea and colitis. World Journal of Gastroenterology 2009; 15(13): 1554-1580 doi: 10.3748/wjg.15.1554
|
26 |
|
27 |
Eamonn MM Quigley. Prebiotics for irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2009; 3(5): 487 doi: 10.1586/egh.09.46
|
28 |
Beth Wallace. Clinical Use of Probiotics in the Pediatric Population. Nutrition in Clinical Practice 2009; 24(1): 50 doi: 10.1177/0884533608329298
|
29 |
Heiner Krammer, Markus Bluhm. Probiotika bei Reizdarmsyndrom. Pharmazie in unserer Zeit 2012; 41(2): 134 doi: 10.1002/pauz.201100461
|
30 |
Loveleen Kaur Sarao, M. Arora. Probiotics, prebiotics, and microencapsulation: A review. Critical Reviews in Food Science and Nutrition 2017; 57(2): 344 doi: 10.1080/10408398.2014.887055
|
31 |
Catherine Ulbricht, Tantri Budiman, Wendy Chao, Shaina Tanguay-Colucci, Julie Conquer, Dawn Costa, Richard Isaac, Joseph Parriott, Amarita Randhawa, Erica Rusie, Jill M. Grimes Serrano, Minney Varghese, Jen Woods, Sara Zhou. Probiotics (Bifidobacterium, Lactobacillus, and Saccharomyces boulardii): An Evidence-Based Systematic Review by the Natural Standard Research Collaboration. Alternative and Complementary Therapies 2011; 17(6): 334 doi: 10.1089/act.2011.17601
|
32 |
I. W. Fong. The Role of Microbes in Common Non-Infectious Diseases. 2014; : 1 doi: 10.1007/978-1-4939-1670-2_1
|
33 |
Jumana Abuqwider, Mohammad Altamimi, Gianluigi Mauriello. Limosilactobacillus reuteri in Health and Disease. Microorganisms 2022; 10(3): 522 doi: 10.3390/microorganisms10030522
|
34 |
Hanneke Bles, Arie Knuistingh Neven. Probiotica bij irritable bowel syndrome. Huisarts en wetenschap 2011; 54(6): 346 doi: 10.1007/s12445-011-0168-y
|
35 |
Ji Hye Jeong, Soojin Jang, Bong Jun Jung, Kyung-Soon Jang, Byung-Gee Kim, Dae Kyun Chung, Hangeun Kim. Differential immune-stimulatory effects of LTAs from different lactic acid bacteria via MAPK signaling pathway in RAW 264.7 cells. Immunobiology 2015; 220(4): 460 doi: 10.1016/j.imbio.2014.11.002
|
36 |
Charlotte Pratt, Matthew D. Campbell. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Probiotics and Antimicrobial Proteins 2020; 12(3): 834 doi: 10.1007/s12602-019-09609-7
|
37 |
Juan José Sebastián Domingo. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterología y Hepatología (English Edition) 2017; 40(6): 417 doi: 10.1016/j.gastre.2016.12.001
|
38 |
Amélie Cayzeele-Decherf, Fanny Pélerin, Sébastien Leuillet, Benoit Douillard, Béatrice Housez, Murielle Cazaubiel, Gunnard K Jacobson, Peter Jüsten, Pierre Desreumaux. <i>Saccharomyces cerevisiae</i> CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World Journal of Gastroenterology 2017; 23(2): 336-344 doi: 10.3748/wjg.v23.i2.336
|
39 |
C. Stevenson, R. Blaauw, E. Fredericks, J. Visser, S. Roux. Food avoidance in irritable bowel syndrome leads to a nutrition-deficient diet. South African Journal of Clinical Nutrition 2014; 27(1): 25 doi: 10.1080/16070658.2014.11734481
|
40 |
John E. Morley. Probiotics and the Nursing Home: Should We Give Bacteria for Breakfast?. Journal of the American Medical Directors Association 2009; 10(6): 365 doi: 10.1016/j.jamda.2009.04.009
|
41 |
Mikihiro Fujiya, Yutaka Kohgo. Novel perspectives in probiotic treatment: the efficacy and unveiled mechanisms of the physiological functions. Clinical Journal of Gastroenterology 2010; 3(3): 117 doi: 10.1007/s12328-010-0154-0
|
42 |
Rodrigo Vázquez-Frias, Alejandra Consuelo-Sánchez, Carlos Patricio Acosta-Rodríguez-Bueno, Andrés Blanco-Montero, Daniel Casas Robles, Vanessa Cohen, Daniel Márquez, Marcos Perez. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Pediatric Drugs 2023; 25(1): 115 doi: 10.1007/s40272-022-00536-9
|
43 |
Eamonn M. M. Quigley. Prebiotics and Probiotics. Nutrition in Clinical Practice 2012; 27(2): 195 doi: 10.1177/0884533611423926
|
44 |
P. Ducrotté. Ballonnement abdominal : où en est-on ?. Gastroentérologie Clinique et Biologique 2009; 33(10-11): F94 doi: 10.1016/j.gcb.2009.08.004
|
45 |
Xing Wang Gao, Mohamed Mubasher, Chong Yu Fang, Cheryl Reifer, Larry E Miller. Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile -Associated Diarrhea Prophylaxis in Adult Patients. American Journal of Gastroenterology 2010; 105(7): 1636 doi: 10.1038/ajg.2010.11
|
46 |
Nicole Bozzi Cionci, Marta Reggio, Loredana Baffoni, Diana Di Gioia. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 219 doi: 10.1007/978-3-031-19564-8_8
|
47 |
Nicola Principi, Rita Cozzali, Edoardo Farinelli, Andrea Brusaferro, Susanna Esposito. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Journal of Infection 2018; 76(2): 111 doi: 10.1016/j.jinf.2017.12.013
|
48 |
C Stevenson, R Blaauw. Probiotics, with special emphasis on their role in the management of irritable bowel syndrome. South African Journal of Clinical Nutrition 2011; 24(2): 63 doi: 10.1080/16070658.2011.11734353
|
49 |
Eleonora Giannetti, Marco Maglione, Annalisa Alessandrella, Caterina Strisciuglio, Donatella De Giovanni, Angelo Campanozzi, Erasmo Miele, Annamaria Staiano. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2017; 51(1): e5 doi: 10.1097/MCG.0000000000000528
|
50 |
Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH, Seckin Bahar SEZGIN. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine. 2022; : 217 doi: 10.2174/9789815051780122010009
|
51 |
Ibrahim Elmadfa, Petra Klein, Alexa L. Meyer. Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proceedings of the Nutrition Society 2010; 69(3): 416 doi: 10.1017/S0029665110001710
|
52 |
Pratima Dibba, Megha Kothari, Irwin Grosman. Nutrition, Weight, and Digestive Health. 2022; : 169 doi: 10.1007/978-3-030-94953-2_11
|
53 |
Stephen M. Collins. A role for the gut microbiota in IBS. Nature Reviews Gastroenterology & Hepatology 2014; 11(8): 497 doi: 10.1038/nrgastro.2014.40
|
54 |
I. Qureshi, J.R. Endres. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013; : 215 doi: 10.1016/B978-0-12-397154-8.00027-0
|
55 |
Oliver Grundmann, Saunjoo L Yoon. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health‐care practitioners. Journal of Gastroenterology and Hepatology 2010; 25(4): 691 doi: 10.1111/j.1440-1746.2009.06120.x
|
56 |
Peter Henningsen, Stephan Zipfel, Heribert Sattel, Francis Creed. Management of Functional Somatic Syndromes and Bodily Distress. Psychotherapy and Psychosomatics 2018; 87(1): 12 doi: 10.1159/000484413
|
57 |
Emmeline Edwards, D. Lee Alekel, Barbara Stussman. Women and Health. 2013; : 57 doi: 10.1016/B978-0-12-384978-6.00005-4
|
58 |
Ashraf MORCOS, Ted DINAN, Eamonn MM QUIGLEY. Irritable bowel syndrome: Role of food in pathogenesis and management. Journal of Digestive Diseases 2009; 10(4): 237 doi: 10.1111/j.1751-2980.2009.00392.x
|
59 |
H. Krammer, M. Bluhm, B. Niesler. Reizdarmsyndrom. CME 2012; 9(12): 41 doi: 10.1007/s11298-012-1705-0
|
60 |
Hale Akpınar. Probiotics and Prebiotics in Food, Nutrition and Health. 2013; : 308 doi: 10.1201/b15561-16
|
61 |
A. N. Suvorov. Microbial personified therapy as an instrument of medical doctor in the future. Russian Journal for Personalized Medicine 2022; 2(1): 51 doi: 10.18705/2782-3806-2022-2-1-51-62
|
62 |
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki, Andrew R Miesner. Irritable bowel syndrome: A concise review of current treatment concepts. World Journal of Gastroenterology 2014; 20(27): 8796 doi: 10.3748/wjg.v20.i27.5796
|
63 |
Marta Caretto, Andrea Giannini, Eleonora Russo, Paolo Mannella, Tommaso Simoncini. Pre-Menopause, Menopause and Beyond. ISGE Series 2018; : 303 doi: 10.1007/978-3-319-63540-8_27
|
64 |
Anat Hershko-Moshe, Yaako’v Hasin, Anat Nevo-Shor, Ohad Etzion, Yaron Ilan, Soe Thiha Maung. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance. GastroHep 2022; 2022: 1 doi: 10.1155/2022/1192547
|
65 |
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2023; : 729 doi: 10.1007/978-3-031-14744-9_52
|
66 |
Silvia Salvatore, Yvan Vandenplas. Bioactive Foods in Promoting Health. 2010; : 181 doi: 10.1016/B978-0-12-374938-3.00013-X
|
67 |
Maneesh Dave, Peter D. Higgins, Sumit Middha, Kevin P. Rioux. The human gut microbiome: current knowledge, challenges, and future directions. Translational Research 2012; 160(4): 246 doi: 10.1016/j.trsl.2012.05.003
|
68 |
Naire Sansotta, Diego G. Peroni, Simone Romano, Anna Rugiano, Pierluigi Vuilleumier, Giuseppe Baviera. The good bugs: the use of probiotics in pediatrics. Current Opinion in Pediatrics 2019; 31(5): 661 doi: 10.1097/MOP.0000000000000808
|
69 |
Mary Ellen Sanders, Maria L. Marco. Food Formats for Effective Delivery of Probiotics. Annual Review of Food Science and Technology 2010; 1(1): 65 doi: 10.1146/annurev.food.080708.100743
|
70 |
Motoyori Kanazawa, Shin Fukudo. Relationship between infectious gastroenteritis and irritable bowel syndrome. Clinical Journal of Gastroenterology 2014; 7(1): 14 doi: 10.1007/s12328-013-0444-4
|
71 |
Robin Spiller, Fanny Pélerin, Amélie Cayzeele Decherf, Corinne Maudet, Béatrice Housez, Murielle Cazaubiel, Peter Jüsten. Randomized double blind placebo-controlled trial ofSaccharomyces cerevisiaeCNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterology Journal 2016; 4(3): 353 doi: 10.1177/2050640615602571
|
72 |
Xiangping Wang, Yikuan Feng, Jiansheng Li, Zibin Tian, Dong Wei, Lingzhi Qi, Lifeng Fang, Kaichun Wu. Routine clinical administration of 4-week alverine citrate and simeticone combination relief global IBS symptoms. Open Journal of Gastroenterology 2014; 4(01): 32 doi: 10.4236/ojgas.2014.41006
|
73 |
Jiayue Gu, Ke Song, Yixuan Fan, Yao Dong, Limin Qian, Zhonghui Gai. Safety evaluation of Bifidobacterium animalis subsp. lactis BLa80 under in vitro, and in vivo conditions. Microbial Pathogenesis 2024; 194: 106809 doi: 10.1016/j.micpath.2024.106809
|
74 |
Marina L. Ritchie, Tamara N. Romanuk, Markus M. Heimesaat. A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLoS ONE 2012; 7(4): e34938 doi: 10.1371/journal.pone.0034938
|
75 |
Gerard E. Mullin, Sue J. Shepherd, Bani Chander Roland, Carol Ireton‐Jones, Laura E. Matarese. Irritable Bowel Syndrome. Journal of Parenteral and Enteral Nutrition 2014; 38(7): 781 doi: 10.1177/0148607114545329
|
76 |
Dirk Haller, Jean-Michel Antoine, Stig Bengmark, Paul Enck, Ger T. Rijkers, Irene Lenoir-Wijnkoop. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel Syndrome1–3. The Journal of Nutrition 2010; 140(3): 690S doi: 10.3945/jn.109.113746
|
77 |
Huan Wang, Jing Gong, Wenfeng Wang, Yanqin Long, Xiaochao Fu, Yu Fu, Wei Qian, Xiaohua Hou, Michael Koval. Are There Any Different Effects of Bifidobacterium, Lactobacillus and Streptococcus on Intestinal Sensation, Barrier Function and Intestinal Immunity in PI-IBS Mouse Model?. PLoS ONE 2014; 9(3): e90153 doi: 10.1371/journal.pone.0090153
|
78 |
Paul J. Kennedy, Gerard Clarke, Eamonn M.M. Quigley, John A. Groeger, Timothy G. Dinan, John F. Cryan. Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome. Neuroscience & Biobehavioral Reviews 2012; 36(1): 310 doi: 10.1016/j.neubiorev.2011.07.001
|
79 |
Christina L. Ohland, Wallace K. MacNaughton. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 298(6): G807 doi: 10.1152/ajpgi.00243.2009
|
80 |
Marguerite Klein, Mary Ellen Sanders, Tri Duong, Howard A. Young. Probiotics: From Bench to Market. Annals of the New York Academy of Sciences 2010; 1212(s1) doi: 10.1111/j.1749-6632.2010.05839.x
|
81 |
Silvia Pisaneschi, Giulia Palla, Stefania Spina, Guja Bernacchi, Elena Cecchi, Silvia Di Bello, Magdalena Montt Guevara, Adrian Campelo, Tommaso Simoncini. Frontiers in Gynecological Endocrinology. ISGE Series 2014; : 215 doi: 10.1007/978-3-319-03494-2_21
|
82 |
Magnus Halland, Nicholas J. Talley. New treatments for IBS. Nature Reviews Gastroenterology & Hepatology 2013; 10(1): 13 doi: 10.1038/nrgastro.2012.207
|
83 |
C. H. Choi, J. G. Kwon, S. K. Kim, S.‐J. Myung, K. S. Park, C.‐I. Sohn, P.‐L. Rhee, K. J. Lee, O. Y. Lee, H.‐K. Jung, S. R. Jee, Y. T. Jeen, M.‐G. Choi, S. C. Choi, K. C. Huh, H. Park. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial. Neurogastroenterology & Motility 2015; 27(5): 705 doi: 10.1111/nmo.12544
|
84 |
Lynne V. McFarland. Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease Specificity. Digestive Diseases and Sciences 2021; 66(3): 694 doi: 10.1007/s10620-020-06244-z
|
85 |
Sang-Hoon Lee, Doo-Yeoun Cho, Seok-Hoon Lee, Kyung-Sun Han, Sung-Won Yang, Jin-Ho Kim, Su-Hyun Lee, Soo-Min Kim, Kyu-Nam Kim. A Randomized Clinical Trial of Synbiotics in Irritable Bowel Syndrome: Dose-Dependent Effects on Gastrointestinal Symptoms and Fatigue. Korean Journal of Family Medicine 2019; 40(1): 2 doi: 10.4082/kjfm.17.0064
|
86 |
Satish Ramraj, Arul Venkatesan. Nutraceuticals and Functional Foods in Human Health and Disease Prevention. 2015; : 629 doi: 10.1201/b19308-55
|
87 |
|
88 |
Gerard E. Mullin. Probiotics and Digestive Disease. Nutrition in Clinical Practice 2012; 27(2): 300 doi: 10.1177/0884533612439609
|
89 |
A. Horvath, P. Dziechciarz, H. Szajewska. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Alimentary Pharmacology & Therapeutics 2011; 33(12): 1302 doi: 10.1111/j.1365-2036.2011.04665.x
|
90 |
Abeer Ahmed Rushdy, Eman Zakaria Gomaa. Antimicrobial compounds produced by probiotic Lactobacillus brevis isolated from dairy products. Annals of Microbiology 2013; 63(1): 81 doi: 10.1007/s13213-012-0447-2
|
91 |
J. König, R.J. Brummer. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 2014; 5(3): 247 doi: 10.3920/BM2013.0033
|
92 |
Amir Mari, Fadi Abu Baker, Mahmud Mahamid, Wisam Sbeit, Tawfik Khoury. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. Journal of Clinical Medicine 2020; 9(3): 685 doi: 10.3390/jcm9030685
|
93 |
Eamonn M. M. Quigley. Probiotics and Irritable Bowel Syndrome. Bioscience and Microflora 2009; 28(4): 119 doi: 10.12938/bifidus.28.119
|
94 |
Oleg Jadrešin, Iva Hojsak, Zrinjka Mišak, Alemka Jaklin Kekez, Tena Trbojević, Lana Ivković, Sanja Kolaček. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(6): 925 doi: 10.1097/MPG.0000000000001478
|
95 |
Yehuda Ringel, Tamar Ringel-Kulka. The Rationale and Clinical Effectiveness of Probiotics in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2011; 45: S145 doi: 10.1097/MCG.0b013e31822d32d3
|
96 |
Frederick Odun-Ayo, Lalini Reddy. Gastrointestinal Microbiota Dysbiosis Associated with SARS-CoV-2 Infection in Colorectal Cancer: The Implication of Probiotics. Gastroenterology Insights 2022; 13(1): 35 doi: 10.3390/gastroent13010006
|
97 |
Michael Camilleri, Emeran A. Mayer. Developing Irritable Bowel Syndrome Guidelines Through Meta-analyses: Does the Emperor Really Have New Clothes?. Gastroenterology 2009; 137(3): 766 doi: 10.1053/j.gastro.2009.07.030
|
98 |
L.V. McFarland. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 145 doi: 10.1016/B978-0-12-804024-9.00018-5
|
99 |
Charles M.A.P. Franz, Melanie Huch, Hikmate Abriouel, Wilhelm Holzapfel, Antonio Gálvez. Enterococci as probiotics and their implications in food safety. International Journal of Food Microbiology 2011; 151(2): 125 doi: 10.1016/j.ijfoodmicro.2011.08.014
|
100 |
Alenka Šmid, Luka Strniša, Katarina Bajc, Dunja Vujić-Podlipec, Bojana Bogovič Matijašić, Irena Rogelj. Randomized clinical trial: The effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacterium BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adults. Journal of Functional Foods 2016; 24: 549 doi: 10.1016/j.jff.2016.04.031
|
101 |
N. Saad, C. Delattre, M. Urdaci, J.M. Schmitter, P. Bressollier. An overview of the last advances in probiotic and prebiotic field. LWT - Food Science and Technology 2013; 50(1): 1 doi: 10.1016/j.lwt.2012.05.014
|
102 |
Suma S Magge, Jacqueline L Wolf. Complementary and Alternative Medicine and Mind–Body Therapies for Treatment of Irritable Bowel Syndrome in Women. Women's Health 2013; 9(6): 557 doi: 10.2217/WHE.13.57
|
103 |
Larysa Hun. Original Research:Bacillus coagulansSignificantly Improved Abdominal Pain and Bloating in Patients with IBS. Postgraduate Medicine 2009; 121(2): 119 doi: 10.3810/pgm.2009.03.1984
|
104 |
Verena Grimm, Christian U. Riedel. Microbiota of the Human Body. Advances in Experimental Medicine and Biology 2016; 902: 109 doi: 10.1007/978-3-319-31248-4_8
|
105 |
Akira Andoh, Takehide Fujimoto, Kenichiro Takahashi. Association between the Gut Microbiota and Intestinal Disorders. Nihon Naika Gakkai Zasshi 2013; 102(11): 2983 doi: 10.2169/naika.102.2983
|
106 |
|
107 |
Lynne V McFarland. State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008. World Journal of Gastroenterology 2008; 14(17): 2625-2629 doi: 10.3748/wjg.14.2625
|
108 |
William D. Heizer, Susannah Southern, Susan McGovern. The Role of Diet in Symptoms of Irritable Bowel Syndrome in Adults: A Narrative Review. Journal of the American Dietetic Association 2009; 109(7): 1204 doi: 10.1016/j.jada.2009.04.012
|
109 |
W. Allan Walker, Kasey Heintz. Protective Nutrients. Nutrition Today 2012; 47(3): 110 doi: 10.1097/NT.0b013e318257b85c
|
110 |
Oscar Brunser, Javier Bravo, Martin Gotteland. Probiotics and Prebiotics in Food, Nutrition and Health. 2013; : 464 doi: 10.1201/b15561-24
|
111 |
Aaron J. Michelfelder, Kit C. Lee, Eva M. Bading. Integrative Medicine and Gastrointestinal Disease. Primary Care: Clinics in Office Practice 2010; 37(2): 255 doi: 10.1016/j.pop.2010.02.003
|
112 |
G. Sisson, S. Ayis, R. A. Sherwood, I. Bjarnason. Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study. Alimentary Pharmacology & Therapeutics 2014; 40(1): 51 doi: 10.1111/apt.12787
|
113 |
Ji-Seon Ahn, Yu-Jin Choi, Han-Byeol Kim, Hea-Jong Chung, Seong-Tshool Hong. Identification of the Intestinal Microbes Associated with Locomotion. International Journal of Molecular Sciences 2023; 24(14): 11392 doi: 10.3390/ijms241411392
|
114 |
Dirk Haller, Gabriele Hörmannsperger. Biofunktionalität der Lebensmittelinhaltsstoffe. Springer-Lehrbuch 2013; : 67 doi: 10.1007/978-3-642-29374-0_6
|
115 |
D. I. Trukhan, V. V. Goloshubina, D. S. Ivanova. Actual issues of diagnosis and treatment of irritable bowel syndrome. Medical Council 2019; (21): 110 doi: 10.21518/2079-701X-2018-21-110-116
|
116 |
Tahreem Riaz, Muhammad Waheed Iqbal, Muhammad Saeed, Iqra Yasmin, Hinawi A. M. Hassanin, Shahid Mahmood, Abdur Rehman. In vitro survival of Bifidobacterium bifidum microencapsulated in zein-coated alginate hydrogel microbeads. Journal of Microencapsulation 2019; 36(2): 192 doi: 10.1080/02652048.2019.1618403
|
117 |
Gareth C. Parkes. Bioactive Foods in Promoting Health. 2010; : 513 doi: 10.1016/B978-0-12-374938-3.00030-X
|
118 |
Ya-Nan Cao, Li-Juan Feng, Yuan-Yuan Liu, Kui Jiang, Mao-Jun Zhang, Yi-Xin Gu, Bang-Mao Wang, Jia Gao, Ze-Lan Wang, Yu-Ming Wang. Effect of <i>Lactobacillus rhamnosus</i> GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome. World Journal of Gastroenterology 2018; 24(3): 338-350 doi: 10.3748/wjg.v24.i3.338
|
119 |
Y. A. McKenzie, J. Thompson, P. Gulia, M. C. E. Lomer. British Dietetic Association systematic review of systematic reviews and evidence‐based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 2016; 29(5): 576 doi: 10.1111/jhn.12386
|
120 |
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterology. Revista de Gastroenterología de México (English Edition) 2017; 82(2): 156 doi: 10.1016/j.rgmxen.2017.03.003
|
121 |
Paul Enck, Florian Junne, Sibylle Klosterhalfen, Stephan Zipfel, Ute Martens. Therapy options in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2010; : 1 doi: 10.1097/MEG.0b013e3283405a17
|
122 |
Kevin Whelan, Eamonn M.M. Quigley. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Current Opinion in Gastroenterology 2013; 29(2): 184 doi: 10.1097/MOG.0b013e32835d7bba
|
123 |
Elizabeth J. Videlock, Lin Chang. Yamada' s Textbook of Gastroenterology. 2015; : 1495 doi: 10.1002/9781118512074.ch75
|
124 |
S. Liptay, S. Burdach. Probiotika bei Kindern und Jugendlichen mit Darmerkrankung. Monatsschrift Kinderheilkunde 2008; 156(11): 1076 doi: 10.1007/s00112-008-1831-7
|
125 |
Hamed Ebrahimzadeh Leylabadlo, Fatemah Sadeghpour Heravi, Elghar Soltani, Amin Abbasi, Hossein Samadi Kafil, Mahdi Parsaei, Sarvin Sanaie, Zainab Ahmadian, Reza Ghotaslou. The role of gut microbiota in the treatment of irritable bowel syndrome. Reviews in Medical Microbiology 2022; 33(1): e89 doi: 10.1097/MRM.0000000000000284
|
126 |
Magnus Simrén. Review: Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?. Therapeutic Advances in Gastroenterology 2009; 2(4_suppl): S5 doi: 10.1177/1756283X09337569
|
127 |
Reizdarmsyndrom wird immer besser verstanden. MMW - Fortschritte der Medizin 2014; 156(19): 60 doi: 10.1007/s15006-014-3643-0
|
128 |
H. Krammer, M. Bluhm, B. Niesler. Reizdarmsyndrom. coloproctology 2012; 34(2): 157 doi: 10.1007/s00053-011-0218-8
|
129 |
A.R. Bhat, V.U. Irorere, T. Bartlett, D. Hill, G. Kedia, D. Charalampopoulos, S. Nualkaekul, I. Radecka. Improving survival of probiotic bacteria using bacterial poly-γ-glutamic acid. International Journal of Food Microbiology 2015; 196: 24 doi: 10.1016/j.ijfoodmicro.2014.11.031
|
130 |
Geoffrey A. Preidis, James Versalovic. Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era. Gastroenterology 2009; 136(6): 2015 doi: 10.1053/j.gastro.2009.01.072
|
131 |
O. F. Ahmad, A. Akbar. Dietary treatment of irritable bowel syndrome. British Medical Bulletin 2015; 113(1): 83 doi: 10.1093/bmb/ldu039
|
132 |
Luise Mølenberg Begtrup, Ove B Schaffalitzky de Muckadell, Jens Kjeldsen, René dePont Christensen, Dorte Ejg Jarbøl. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology 2013; 48(10): 1127 doi: 10.3109/00365521.2013.825314
|
133 |
S. Guandalini, E. Cernat, D. Moscoso. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Beneficial Microbes 2015; 6(2): 209 doi: 10.3920/BM2014.0067
|
134 |
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterología. Revista de Gastroenterología de México 2017; 82(2): 156 doi: 10.1016/j.rgmx.2016.08.004
|
135 |
Shenghui Zhou, Xiaoli Liu, Xiaoxia Wang, Fenglin Xi, Xiaoke Luo, Liang Yao, Hao Tang. Pharmacological and non-pharmacological treatments for irritable bowel syndrome. Medicine 2019; 98(30): e16446 doi: 10.1097/MD.0000000000016446
|
136 |
Dirk Haller, Gerald Rimbach, Tilman Grune. Biofunktionalität der Lebensmittelinhaltsstoffe. Springer-Lehrbuch 2013; : 281 doi: 10.1007/978-3-642-29374-0_21
|
137 |
Carlo M. Bergamini, Nicoletta Bianchi, Valerio Giaccone, Paolo Catellani, Leonardo Alberghini, Alessandra Stella, Stefano Biffani, Sachithra Kalhari Yaddehige, Tania Bobbo, Cristian Taccioli. Machine Learning Algorithms Highlight tRNA Information Content and Chargaff’s Second Parity Rule Score as Important Features in Discriminating Probiotics from Non-Probiotics. Biology 2022; 11(7): 1024 doi: 10.3390/biology11071024
|
138 |
Nazar Mazurak, Ellen Broelz, Martin Storr, Paul Enck. Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?. Journal of Neurogastroenterology and Motility 2015; 21(4): 471 doi: 10.5056/jnm15071
|
139 |
Y. A. McKenzie, R. K. Bowyer, H. Leach, P. Gulia, J. Horobin, N. A. O'Sullivan, C. Pettitt, L. B. Reeves, L. Seamark, M. Williams, J. Thompson, M. C. E. Lomer. British Dietetic Association systematic review and evidence‐based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 2016; 29(5): 549 doi: 10.1111/jhn.12385
|
140 |
Lynne V. McFarland, Tarkan Karakan, Ali Karatas. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. eClinicalMedicine 2021; 41: 101154 doi: 10.1016/j.eclinm.2021.101154
|
141 |
Linda V. Thomas, Kaori Suzuki, Jia Zhao. Probiotics: a proactive approach to health. A symposium report. British Journal of Nutrition 2015; 114(S1): S1 doi: 10.1017/S0007114515004043
|
142 |
P. Enck, K. Zimmermann, K. Rusch, A. Schwiertz, S. Klosterhalfen, J. S. Frick. The Effects of Maturation on the Colonic Microflora in Infancy and Childhood. Gastroenterology Research and Practice 2009; 2009: 1 doi: 10.1155/2009/752401
|
143 |
S. Shukla, A. Shukla, S. Mehboob, S. Guha. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Alimentary Pharmacology & Therapeutics 2011; 33(6): 662 doi: 10.1111/j.1365-2036.2010.04574.x
|
144 |
Randal Buddington. Prebiotics and Probiotics Science and Technology. 2009; : 1 doi: 10.1007/978-0-387-79058-9_1
|
145 |
Wojciech Marlicz, Diana E Yung, Karolina Skonieczna-Żydecka, Igor Loniewski, Saskia van Hemert, Beata Loniewska, Anastasios Koulaouzidis. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 961 doi: 10.1080/17474124.2017.1343664
|
146 |
Wolfgang Kruis, Sigrun Chrubasik, Stephan Boehm, Christiane Stange, Juergen Schulze. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. International Journal of Colorectal Disease 2012; 27(4): 467 doi: 10.1007/s00384-011-1363-9
|
147 |
Stefano Guandalini, Giuseppe Magazzù, Andrea Chiaro, Valeria La Balestra, Giovanni Di Nardo, Sarath Gopalan, A Sibal, Claudio Romano, Roberto Berni Canani, Paolo Lionetti, Mala Setty. VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo‐Controlled, Double‐Blind, Crossover Study. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(1): 24 doi: 10.1097/MPG.0b013e3181ca4d95
|
148 |
K. Hod, A. D. Sperber, Y. Ron, M. Boaz, R. Dickman, S. Berliner, Z. Halpern, N. Maharshak, R. Dekel. A double‐blind, placebo‐controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea‐predominant IBS. Neurogastroenterology & Motility 2017; 29(7) doi: 10.1111/nmo.13037
|
149 |
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2017; : 639 doi: 10.1007/978-3-319-49215-5_52
|
150 |
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2013; : 505 doi: 10.1007/978-1-4614-5061-0_46
|
151 |
Anna Lyra, Lotta Krogius-Kurikka, Janne Nikkilä, Erja Malinen, Kajsa Kajander, Kyösti Kurikka, Riitta Korpela, Airi Palva. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-110
|
152 |
Elvina Parlindungan, Oliver A. H. Jones. Using metabolomics to understand stress responses in Lactic Acid Bacteria and their applications in the food industry. Metabolomics 2023; 19(12) doi: 10.1007/s11306-023-02062-2
|
153 |
Jee-Yon Lee, Sang-Hui Chu, Justin Y. Jeon, Mi-Kyung Lee, Ji-Hye Park, Duk-Chul Lee, Ji-Won Lee, Nam-Kyu Kim. Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial. Digestive and Liver Disease 2014; 46(12): 1126 doi: 10.1016/j.dld.2014.09.004
|
154 |
Helen L. Mitchell, Peter J. Aggett, David P. Richardson, Julian D. Stowell. Food & health forum meeting: evidence-based nutrition. British Journal of Nutrition 2011; 105(2): 322 doi: 10.1017/S0007114510003296
|
155 |
H. L. DuPont. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary Pharmacology & Therapeutics 2014; 39(10): 1033 doi: 10.1111/apt.12728
|
156 |
|
157 |
Riaz A. Agha, Christian F. Camm, Eric Edison, Dennis P. Orgill. The methodological quality of randomized controlled trials in plastic surgery needs improvement: A systematic review. Journal of Plastic, Reconstructive & Aesthetic Surgery 2013; 66(4): 447 doi: 10.1016/j.bjps.2012.11.005
|
158 |
Eamonn M.M. Quigley. Probiotics in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2015; 49(Supplement 1): S60 doi: 10.1097/MCG.0000000000000348
|
159 |
Kevin Whelan. Probiotics and prebiotics in the management of irritable bowel syndrome. Current Opinion in Clinical Nutrition and Metabolic Care 2011; 14(6): 581 doi: 10.1097/MCO.0b013e32834b8082
|
160 |
Denis Guyonnet, Armelle Schlumberger, Leila Mhamdi, Stefan Jakob, Olivier Chassany. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. British Journal of Nutrition 2009; 102(11): 1654 doi: 10.1017/S0007114509990882
|
161 |
Riitta Korpela, Leena Niittynen. Probiotics and Irritable Bowel Syndrome. Microbial Ecology in Health & Disease 2012; 23(0) doi: 10.3402/mehd.v23i0.18573
|
162 |
Gerard Mullin. Gastrointestinal and Liver Disease Nutrition Desk Reference. 2011; : 21 doi: 10.1201/b11184-4
|
163 |
Joaquim Prado MORAES-FILHO, Eamonn M M QUIGLEY. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review. Arquivos de Gastroenterologia 2015; 52(4): 331 doi: 10.1590/S0004-28032015000400015
|
164 |
Uday C Ghoshal, Hyojin Park, Kok‐Ann Gwee. Bugs and irritable bowel syndrome: The good, the bad and the ugly. Journal of Gastroenterology and Hepatology 2010; 25(2): 244 doi: 10.1111/j.1440-1746.2009.06133.x
|
165 |
T. Yakabe, E.L. Moore, S. Yokota, H. Sui, Y. Nobuta, M. Fukao, H. Palmer, N. Yajima. Safety assessment of Lactobacillus brevis KB290 as a probiotic strain. Food and Chemical Toxicology 2009; 47(10): 2450 doi: 10.1016/j.fct.2009.07.001
|
166 |
E. Weichselbaum. Probiotics and health: a review of the evidence. Nutrition Bulletin 2009; 34(4): 340 doi: 10.1111/j.1467-3010.2009.01782.x
|
167 |
Sumel Ashique, Tuhin Mukherjee, Satyajit Mohanty, Ashish Garg, Neeraj Mishra, Monika Kaushik, Mithun Bhowmick, Bornika Chattaraj, Sourav Mohanto, Shriyansh Srivastava, Farzad Taghizadeh-Hesary. Blueberries in focus: Exploring the phytochemical potentials and therapeutic applications. Journal of Agriculture and Food Research 2024; 18: 101300 doi: 10.1016/j.jafr.2024.101300
|
168 |
Paolo Mannella, Giulia Palla, Massimo Bellini, Tommaso Simoncini. The female pelvic floor through midlife and aging. Maturitas 2013; 76(3): 230 doi: 10.1016/j.maturitas.2013.08.008
|
169 |
Daniel Villageliú, Mark Lyte, Palok Aich. Dopamine production in Enterococcus faecium: A microbial endocrinology-based mechanism for the selection of probiotics based on neurochemical-producing potential. PLOS ONE 2018; 13(11): e0207038 doi: 10.1371/journal.pone.0207038
|
170 |
Alexander SUVOROV. Gut Microbiota, Probiotics, and Human Health. Bioscience of Microbiota, Food and Health 2013; 32(3): 81 doi: 10.12938/bmfh.32.81
|
171 |
Julia-Stefanie Frick, Ingo B. Autenrieth. Between Pathogenicity and Commensalism. Current Topics in Microbiology and Immunology 2012; 358: 273 doi: 10.1007/82_2012_217
|
172 |
Fifi M. Reda, Azza Z. Refaie.
Purification and characterization of pedioxanthin (carotenoid pigment) produced by
Pediococcus pentosaceus
N33 strain isolated from pickles
. Food Biotechnology 2019; 33(3): 217 doi: 10.1080/08905436.2019.1617166
|
173 |
Xue Shang, Fen-Fen E, Kang-Le Guo, Yan-Fei Li, Hong-Lin Zhao, Yan Wang, Nan Chen, Tao Nian, Chao-Qun Yang, Ke-Hu Yang, Xiu-Xia Li. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials. Nutrients 2022; 14(12): 2482 doi: 10.3390/nu14122482
|
174 |
Hao ZHANG, Jing SUN, Qing-yu WANG, Yu-tong HE, Hui-yong GU, Hui-yuan GUO, Qing-bo DING, Jun-si YANG, Fa-zheng REN. Safety Assessment of Lactobacillus salivarius REN, a Probiotic Strain Isolated from Centenarian Feces. Food Science and Technology Research 2013; 19(6): 1037 doi: 10.3136/fstr.19.1037
|
175 |
M. de Greck, P. Layer, V. Andresen. Schmerztherapie beim Reizdarmsyndrom. Der Schmerz 2014; 28(3): 289 doi: 10.1007/s00482-014-1406-6
|
176 |
J.R. Endres, A. Clewell, K.A. Jade, T. Farber, J. Hauswirth, A.G. Schauss. Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 2009; 47(6): 1231 doi: 10.1016/j.fct.2009.02.018
|
177 |
Emeran A. Mayer, Tor Savidge, Robert J. Shulman. Brain–Gut Microbiome Interactions and Functional Bowel Disorders. Gastroenterology 2014; 146(6): 1500 doi: 10.1053/j.gastro.2014.02.037
|
178 |
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki, Andrew R Miesner. Irritable bowel syndrome: A concise review of current treatment concepts. World Journal of Gastroenterology 2014; 20(27): 8796-8806 doi: 10.3748/wjg.v20.i27.8796
|
179 |
Asieh Hosseini, Shekoufeh Nikfar, Mohammad Abdollahi. Probiotics use to treat irritable bowel syndrome. Expert Opinion on Biological Therapy 2012; 12(10): 1323 doi: 10.1517/14712598.2012.707179
|
180 |
Nurzulaikha Abdullah, Yee Cheng Kueh, Garry Kuan, Mung Seong Wong, Fatan Hamamah Yahaya, Nor Aslina Abd Samat, Khairil Khuzaini Zulkifli, Yeong Yeh Lee. Development and validation of the Health Promoting Behaviour for Bloating (HPB-Bloat) scale. PeerJ 2021; 9: e11444 doi: 10.7717/peerj.11444
|
181 |
Chander Shekhar, Peter J Whorwell. Emerging drugs for irritable bowel syndrome. Expert Opinion on Emerging Drugs 2009; 14(4): 673 doi: 10.1517/14728210903222279
|
182 |
K. Preston, R. Krumian, J. Hattner, D. de Montigny, M. Stewart, S. Gaddam. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. Beneficial Microbes 2018; 9(5): 697 doi: 10.3920/BM2017.0105
|
183 |
Sonia Michail, Harshavardhan Kenche. Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome. Probiotics and Antimicrobial Proteins 2011; 3(1): 1 doi: 10.1007/s12602-010-9059-y
|
184 |
Mark Pimentel, Christopher Chang. Inflammation and Microflora. Gastroenterology Clinics of North America 2011; 40(1): 69 doi: 10.1016/j.gtc.2010.12.010
|
185 |
Sadegh Sulaimany, Kajal Farahmandi, Aso Mafakheri. Computational prediction of new therapeutic effects of probiotics. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62796-4
|
186 |
Saif Ul Islam. Clinical Uses of Probiotics. Medicine 2016; 95(5): e2658 doi: 10.1097/MD.0000000000002658
|
187 |
Michael Camilleri, Carlo Di Lorenzo. Brain‐Gut Axis. Journal of Pediatric Gastroenterology and Nutrition 2012; 54(4): 446 doi: 10.1097/MPG.0b013e31823d34c3
|
188 |
B. Duncan. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013; : 449 doi: 10.1016/B978-0-12-397154-8.00005-1
|
189 |
María Torres‑Chávez, Nora Torres‑Carrillo, Ana Moreal‑Lugo, Sandra Garnés‑Rancurello, Selvasankar Murugesan, Itzae Gutiérrez‑Hurtado, Jesús Beltrán‑Ramírez, Elena Sandoval‑Pinto, Norma Torres‑Carrillo. Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review). Biomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1675
|
190 |
|
191 |
Stefano Guandalini. Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?. Frontiers in Medicine 2014; 1 doi: 10.3389/fmed.2014.00023
|
192 |
Q. Aziz, J. Doré, A. Emmanuel, F. Guarner, E. M. M. Quigley. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterology & Motility 2013; 25(1): 4 doi: 10.1111/nmo.12046
|
193 |
Thanitsara Rittiphairoj, Krit Pongpirul, Noel T. Mueller, Tianjing Li. Probiotics for glycemic control in patients with type 2 diabetes mellitus: protocol for a systematic review. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-1145-y
|
194 |
G. Malaguarnera, F. Leggio, M. Vacante, M. Motta, M. Giordano, A. Biondi, F. Basile, S. Mastrojeni, A. Mistretta, Mariano Malaguarnera, M.A. Toscano, M. Salmeri. Probiotics in the gastrointestinal diseases of the elderly. The Journal of nutrition, health and aging 2012; 16(4): 402 doi: 10.1007/s12603-011-0357-1
|
195 |
Dorit Vedel Ankersen, Petra Weimers, Mette Bennedsen, Anne Birgitte Haaber, Eva Lund Fjordside, Moritz Emanuel Beber, Christian Lieven, Sanaz Saboori, Nicolai Vad, Terje Rannem, Dorte Marker, Kristine Paridaens, Suzanne Frahm, Lisbeth Jensen, Malte Rosager Hansen, Johan Burisch, Pia Munkholm. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial. Journal of Medical Internet Research 2021; 23(12): e30291 doi: 10.2196/30291
|
196 |
Ami PATEL, Nihir SHAH. Potentials of probiotics in the treatment of food allergy - a review. Czech Journal of Food Sciences 2014; 32(3): 205 doi: 10.17221/200/2013-CJFS
|
197 |
T. Piche. Anomalies pariétales et de la flore au cours du syndrome de l’intestin irritable. Gastroentérologie Clinique et Biologique 2009; 33: S40 doi: 10.1016/S0399-8320(09)71524-6
|
198 |
Stefano Guandalini. The Potential for use of Probiotics in Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease. Current Pediatrics Reports 2014; 2(3): 235 doi: 10.1007/s40124-014-0050-z
|
199 |
Eamonn M.M. Quigley. Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies. Gastroenterology Clinics of North America 2011; 40(1): 207 doi: 10.1016/j.gtc.2010.12.009
|
200 |
Eamonn M. M. Quigley. Probiotics in Gastrointestinal Disorders. Hospital Practice 2010; 38(4): 122 doi: 10.3810/hp.2010.11.349
|
201 |
L. Foster, T. Tompkins, W. Dahl. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Beneficial Microbes 2011; 2(4): 319 doi: 10.3920/BM2011.0032
|
202 |
Annalisa Passariello, Pascal Agricole, Peter Malfertheiner. A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases. Current Medical Research and Opinion 2014; 30(6): 1055 doi: 10.1185/03007995.2014.898138
|
203 |
Yi-Heng Chiu, Ying-Chen Lu, Chu-Chyn Ou, Shiao-Lin Lin, Chin-Chi Tsai, Chien-Tsai Huang, Meei-Yn Lin. Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells. BMC Microbiology 2013; 13(1) doi: 10.1186/1471-2180-13-190
|
204 |
Dominika Winiarz, Kamila Domańska, Kinga Paluch, Dorota Dorota Skrajnowska. PROBIOTYKI A ZDROWIE - DZIŚ I JUTRO. Prospects in Pharmaceutical Sciences 2017; 15(10): 86 doi: 10.56782/pps.82
|
205 |
J.R. Endres, I. Qureshi, T. Farber, J. Hauswirth, G. Hirka, I. Pasics, A.G. Schauss. One-year chronic oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 2011; 49(5): 1174 doi: 10.1016/j.fct.2011.02.012
|
206 |
Zaigham Abbas, Javed Yakoob, Wasim Jafri, Zubair Ahmad, Zahid Azam, Muhammad W. Usman, Sara Shamim, Muhammad Islam. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2014; 26(6): 630 doi: 10.1097/MEG.0000000000000094
|
207 |
Beom Jae Lee, Young-Tae Bak. Irritable Bowel Syndrome, Gut Microbiota and Probiotics. Journal of Neurogastroenterology and Motility 2011; 17(3): 252 doi: 10.5056/jnm.2011.17.3.252
|
208 |
Geoffrey A. Preidis, Bruno P. Chumpitazi, Robert J. Shulman. Pediatric Neurogastroenterology. 2017; : 53 doi: 10.1007/978-3-319-43268-7_5
|
209 |
Keren Hod, Yehuda Ringel. Probiotics in functional bowel disorders. Best Practice & Research Clinical Gastroenterology 2016; 30(1): 89 doi: 10.1016/j.bpg.2016.01.003
|
210 |
K. Hod, Y. Ringel. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 355 doi: 10.1016/B978-0-12-804024-9.00038-0
|
211 |
Stephen M Vindigni, Elizabeth K Broussard, Christina M Surawicz. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics forClostridium difficileand beyond. Expert Review of Gastroenterology & Hepatology 2013; 7(7): 615 doi: 10.1586/17474124.2013.832501
|
212 |
Nancy Toedter Williams. Probiotics. American Journal of Health-System Pharmacy 2010; 67(6): 449 doi: 10.2146/ajhp090168
|
213 |
Hamish Philpott, Sanjay Nandurkar, John Lubel, Peter R Gibson. Alternative investigations for irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2013; 28(1): 73 doi: 10.1111/j.1440-1746.2012.07291.x
|
214 |
Julia König, Ignacio Rangel, Robert J. Brummer. The Role of Lactic Acid Bacteria in the Pathophysiology and Treatment of Irritable Bowel Syndrome (IBS). Food and Nutrition Sciences 2013; 4(11): 27 doi: 10.4236/fns.2013.411A005
|
215 |
Richard Glickman-Simon, Indranill Basu Ray. Acupuncture, Lactobacillus Traditional Chinese Herbal Medicine, Sanchitongtshu, and Honey. EXPLORE 2012; 8(5): 310 doi: 10.1016/j.explore.2012.06.009
|
216 |
Juan José Sebastián Domingo. Revisión del papel de los probióticos en la patología gastrointestinal del adulto. Gastroenterología y Hepatología 2017; 40(6): 417 doi: 10.1016/j.gastrohep.2016.12.003
|
217 |
Kajal Farahmandi, Sadegh Sulaimany. Advances in Probiotics for Health and Nutrition. 2024; doi: 10.5772/intechopen.109717
|
218 |
M.J. Hosseini ., R. Ranjbar ., H. Ghasemi ., H.R. Jalalian .. The Prevalence and Antibiotic Resistance of Shigella sp. Recovered from Patients Admitted to Bouali Hospital, Tehran, Iran During 1999-2001. Pakistan Journal of Biological Sciences 2007; 10(16): 2778 doi: 10.3923/pjbs.2007.2778.2780
|
219 |
Mariana Buranelo Egea, Josemar Gonçalves de Oliveira Filho, Ailton Cesar Lemes. Investigating the Efficacy of Saccharomyces boulardii in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far. International Journal of Molecular Sciences 2023; 24(15): 12015 doi: 10.3390/ijms241512015
|
220 |
Bo Søndergaard, Johan Olsson, Kajsa Ohlson, Ulla Svensson, Peter Bytzer, Rickard Ekesbo. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial. Scandinavian Journal of Gastroenterology 2011; 46(6): 663 doi: 10.3109/00365521.2011.565066
|
221 |
Devaraja Gayathri, Alurappa Ramesha. Gluten‑hydrolyzing probiotics: An emerging therapy for patients with celiac disease (Review). World Academy of Sciences Journal 2020; doi: 10.3892/wasj.2020.55
|
222 |
M. SIMRÉN, L. ÖHMAN, J. OLSSON, U. SVENSSON, K. OHLSON, I. POSSERUD, H. STRID. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome – a randomized, double‐blind, controlled study. Alimentary Pharmacology & Therapeutics 2010; 31(2): 218 doi: 10.1111/j.1365-2036.2009.04183.x
|
223 |
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, E. V. Shikh. Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii. Meditsinskiy sovet = Medical Council 2020; (5): 104 doi: 10.21518/2079-701X-2020-5-104-112
|
224 |
Rebecca Taylor. What are functional foods and what they can do?. Nursing and Residential Care 2011; 13(2): 72 doi: 10.12968/nrec.2011.13.2.72
|
225 |
Natalia Pedersen, Nynne Nyboe Andersen, Zsuzsanna Végh, Lisbeth Jensen, Dorit Vedel Ankersen, Maria Felding, Mette Hestetun Simonsen, Johan Burisch, Pia Munkholm. Ehealth: Low FODMAP diet <italic>vs Lactobacillus rhamnosus</italic> GG in irritable bowel syndrome. World Journal of Gastroenterology 2014; 20(43): 16215-16226 doi: 10.3748/wjg.v20.i43.16215
|
226 |
Hannah Claire Baker, Dang Ngoc Tran, Linda Valerie Thomas. Health benefits of probiotics for the elderly: a review. Journal of Foodservice 2009; 20(5): 250 doi: 10.1111/j.1748-0159.2009.00147.x
|
227 |
Leonilde Bonfrate, Jan Tack, Ignazio Grattagliano, Rosario Cuomo, Piero Portincasa. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scandinavian Journal of Gastroenterology 2013; 48(9): 995 doi: 10.3109/00365521.2013.799220
|
228 |
Fredrick Asare, Stine Störsrud, Magnus Simrén. Meditation over Medication for Irritable Bowel Syndrome? On Exercise and Alternative Treatments for Irritable Bowel Syndrome. Current Gastroenterology Reports 2012; 14(4): 283 doi: 10.1007/s11894-012-0268-2
|
229 |
Ahmed E. Salem, Rajdeep Singh, Younan K. Ayoub, Ahmed M. Khairy, Gerard E. Mullin. The gut microbiome and irritable bowel syndrome: State of art review. Arab Journal of Gastroenterology 2018; 19(3): 136 doi: 10.1016/j.ajg.2018.02.008
|
230 |
Wai-Yee Fung, Huey-Shi Lye, Ting-Jin Lim, Chiu-Yin Kuan, Min-Tze Liong. Probiotics. Microbiology Monographs 2011; 21: 139 doi: 10.1007/978-3-642-20838-6_6
|
231 |
Lynne V McFarland. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 2014; 4(8): e005047 doi: 10.1136/bmjopen-2014-005047
|
232 |
Fariba Tarhani, Alireza Nezami. Role of probiotics in treatment of congenital heart disease and necrotizing enterocolitis. PharmaNutrition 2019; 8: 100144 doi: 10.1016/j.phanu.2019.100144
|
233 |
Julia König, Robert-Jan Brummer. Pharma-Nutrition. AAPS Advances in the Pharmaceutical Sciences Series 2014; 12: 55 doi: 10.1007/978-3-319-06151-1_4
|
234 |
K. Nobutani, D. Sawada, S. Fujiwara, Y. Kuwano, K. Nishida, J. Nakayama, H. Kutsumi, T. Azuma, K. Rokutan. The effects of administration of theLactobacillus gasseristrain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome. Journal of Applied Microbiology 2017; 122(1): 212 doi: 10.1111/jam.13329
|
235 |
Theodoros Kelesidis, Charalabos Pothoulakis. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic Advances in Gastroenterology 2012; 5(2): 111 doi: 10.1177/1756283X11428502
|
236 |
Jalal Moludi, Amir Saber, Morteza Arab Zozani, Shima Moradi, Yasaman Azamian, Salimeh Hajiahmadi, Yahya Pasdar, Fardin Moradi. The Efficacy of Probiotics Supplementation on the Quality of Life of Patients with Gastrointestinal Disease: A Systematic Review of Clinical Studies. Preventive Nutrition and Food Science 2024; 29(3): 237 doi: 10.3746/pnf.2024.29.3.237
|